Fiscal year 24 arthritis research program
Ended Awarded Last action
- Contract number
- HT942524F0263
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $155,719
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 67% obligated
- $232,164.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$76,446 | |
| Terminate for Convenience | $0 | |
| Original award | $232,165 |
About this award
Leidos, Inc. (operating as SAIC under its Leidos Services Operating Segment) has been awarded a cost-plus-fixed-fee delivery order valued at $232,164.80 by the Defense Health Agency to support the Fiscal Year 24 Arthritis Research Program. The delivery order, issued on September 1, 2024, represents additional funding to complete ongoing arthritis research efforts, with work to be performed in Frederick, Maryland through June 30, 2025. This award was made without a set-aside designation, reflecting Leidos' competitive standing as a prime contractor. The Defense Health Agency, operating under the Department of Defense, administers medical research programs addressing various conditions affecting military personnel and beneficiaries, and arthritis research aligns with the agency's portfolio of clinical and translational research initiatives.
As a delivery order under a larger indefinite delivery contract, this award represents a task order issuance for specific research program support activities. Leidos, a global technology and engineering solutions provider with extensive experience across defense and health sectors, regularly executes medical research support contracts for federal agencies including the Defense Health Agency and the National Cancer Institute. The company's Leidos Services Operating Segment, through its SAIC division, brings substantial capabilities in scientific research program management, technical support, and administrative services necessary to advance arthritis-related research objectives for the Department of Defense.
Quick answers
Who was awarded contract HT942524F0263?
HT942524F0263 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on September 1, 2024.
How much is contract HT942524F0263 worth?
The government has obligated $155,719 on HT942524F0263. Its current value, with exercised options, is $232,165.
Is contract HT942524F0263 an order under another contract?
Yes. HT942524F0263 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942524F0263 competed?
The extent of competition for HT942524F0263 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award